The emblem of the state corporation «Rostec». Archive photo MOSCOW, Jan. 4 In 2022, Rostec will present the first results of the development of a unified vaccine against influenza and coronavirus, the head of the state corporation Sergei Chemezov told RIA Novosti.
& # 34; While working. Next year. It is necessary to conduct all the tests so that it is safe, above all, and effective & # 34 ;, — he said.
Chemezov added that there are already good research results, but there are still things that still need to be improved. Vaccination remains the most reliable a way to protect against COVID-19. According to the head of the Russian Ministry of Health Mikhail Murashko, the proportion of vaccinated among those infected with coronavirus does not exceed four percent. The vaccine can be done in any Russian region. In August last year, the Ministry of Health registered Sputnik V, the world's first drug for the prevention of COVID-19, developed by the Gamaleya Research Center for Electrochemistry. Also in Russia, vaccines «EpiVacCorona» were created from the «Vector» Center of Rospotrebnadzor and «KoviVak» from the Chumakov Center of the Russian Academy of Sciences. At the beginning of May 2021, it became known about the registration of the fourth domestic drug «Sputnik Light», and at the end of August — » «from» Vector «. In November, the first Russian vaccine for adolescents, Gam-COVID-Vac M, was approved. 